Research Article Volume 7 Issue 1
Received: June 05, 2023 | Published: June 26, 2023
A promising family of 17-HSD3 inhibitors with potential uses in treating androgen-dependent disorders includes benzylidene oxazolidinedione and thiazolidinedione derivatives.
Keywords: quantitative structure–activity relationship, benzylidene oxazolidinedione, thiazolidinedione derivatives, 17-HSD3 inhibitors
©2023 , et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.